民众担心会泄露隐私，媒体谈论是官商勾结，美卫生部长“带货”健康监测设备挨批

Core Points - The U.S. Department of Health and Human Services aims to have all Americans wear health monitoring devices within four years, as part of the "Make America Healthy Again" agenda [1][3] - The initiative has raised concerns about privacy and data security, as health data may be collected and sold without user consent [3][4] - The cost of continuous glucose monitoring devices is high, ranging from $100 to $300 per month, but the government is exploring ways to make these devices more affordable [3] Group 1 - The push for wearable health monitoring devices is seen as a key component of the government's health agenda, with the Secretary of Health promoting their benefits for personal health management [1][3] - Concerns have been raised regarding the potential for anxiety and over-diagnosis among users of these devices, as well as the risk of misuse of medical terminology in marketing [3][4] - Following the Secretary's promotion, stock prices for glucose monitoring device manufacturers Abbott and Dexcom rose by 3.6% and 10%, respectively, indicating potential market interest [4] Group 2 - Allegations of conflicts of interest have emerged, with claims that the Secretary had prior meetings with pharmaceutical executives, raising questions about the integrity of the health agenda [4] - The "Make America Healthy Again" initiative has faced criticism for causing significant disruptions within the healthcare system, including the dismissal of over 10,000 health department employees and the halting of numerous medical research projects [4] - Some former employees believe that the changes brought by the initiative may worsen public health outcomes, with one CDC manager openly criticizing the Secretary's leadership [4]